España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
BeiGene
BGNE
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$154.74
0
0.00%
Last update: Jul 19, 4:00 PM
15 minutes delayed
Get Report
Comment
BeiGene (BGNE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for BeiGene (NASDAQ:BGNE) Stock
BeiGene Stock (NASDAQ: BGNE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 18, 2024
Beigene Has Appointed Aaron Rosenberg As Chie...
Benzinga Newsdesk
Tuesday, July 09, 2024
B of A Securities Maintains Neutral on BeiGen...
Benzinga Newsdesk
Sunday, June 30, 2024
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
Lekha Gupta
Monday, June 17, 2024
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
Vandana Singh
Friday, June 14, 2024
BeiGene Says It Will Present New Data From SE...
Benzinga Newsdesk
Tuesday, May 28, 2024
BriaCell Therapeutics Announces Clinical Supp...
Benzinga Newsdesk
Sunday, May 26, 2024
Lululemon Athletica Was Among The Worst-Performing Stocks Last Week (May 19-May 26, 2024): Are These 10 Large-Cap Stock Losers In Your Portfolio?
Lekha Gupta
Friday, May 24, 2024
BeiGene Says BRUKINSA Data At American Societ...
Benzinga Newsdesk
Thursday, May 23, 2024
BeiGene's Aggressive Expansion Brings Revenue Jolt
The Bamboo Works
Tuesday, May 14, 2024
BeiGene To Highlight New Hematology Portfolio...
Benzinga Newsdesk
Thursday, May 09, 2024
TD Cowen Maintains Buy on BeiGene, Raises Pri...
Benzinga Newsdesk
Wednesday, May 08, 2024
BeiGene shares are trading higher after the c...
Benzinga Newsdesk
BeiGene Q1 2024 GAAP EPADS $(2.41) Beats $(2....
Benzinga Newsdesk
Sunday, April 28, 2024
Tracking Last Week's Top Performers: Are These 15 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
Lekha Gupta
Friday, April 26, 2024
Hillhouse Boosts Longi Position After Robe, As It Pivots To Global Focus
The Bamboo Works
Wednesday, April 24, 2024
Evaluating BeiGene: Insights From 6 Financial Analysts
Benzinga Insights
TD Cowen Maintains Buy on BeiGene, Raises Pri...
Benzinga Newsdesk
BeiGene shares are trading higher after the E...
Benzinga Newsdesk
Tuesday, April 23, 2024
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
BeiGene shares are trading higher after the E...
Benzinga Newsdesk
The European Commission Approves BeiGene's Ti...
Benzinga Newsdesk
Friday, April 12, 2024
Shares of US-listed Chinese stocks are tradin...
Benzinga Newsdesk
Monday, April 08, 2024
B of A Securities Maintains Neutral on BeiGen...
Benzinga Newsdesk
Thursday, March 28, 2024
Genfleet Therapeutics Announced Clinical Tria...
Benzinga Newsdesk
Wednesday, March 27, 2024
4 Analysts Assess BeiGene: What You Need To Know
Benzinga Insights
Bernstein Maintains Market Perform on BeiGene...
Benzinga Newsdesk
Friday, March 22, 2024
Lululemon Issues Weak Outlook, Joins Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Friday, March 15, 2024
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
Vandana Singh
Thursday, March 14, 2024
BeiGene Secures FDA Approval For TEVIMBRA For...
Benzinga Newsdesk
FDA Approves Beigene's Tevimbra As Of March 1...
Benzinga Newsdesk
Wednesday, March 13, 2024
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
First Doses Of BRUKINSA Provided To Patients ...
Benzinga Newsdesk
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Avi Kapoor
Friday, March 08, 2024
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
Vandana Singh
Beigene Said It Filed Patent Infringement Suits Against Sandoz, MSN Pharmaceuticals
Charles Gross
Thursday, March 07, 2024
BeiGene Announces FDA Accelerated Approval Of...
Benzinga Newsdesk
Thursday, February 29, 2024
BeiGene Announces Efficacy Analysis Comparing...
Benzinga Newsdesk
Tuesday, February 27, 2024
BeiGene shares are trading higher after the c...
Benzinga Newsdesk
Guggenheim Maintains Buy on BeiGene, Lowers P...
Benzinga Newsdesk
BeiGene's Biologics License Application for T...
Benzinga Newsdesk
Monday, February 26, 2024
BeiGene Q4 EPADS $(3.53) Beats $(3.73) Estima...
Benzinga Newsdesk
The Committee For Medicinal Products For Huma...
Benzinga Newsdesk
Tuesday, February 20, 2024
BeiGene (BGNE) to Report Q4 Earnings: What's in the Cards?
Zacks
Friday, February 16, 2024
Hang Seng Index Set For Global Expansion With Prada, XPeng, And BeiGene On The Horizon
Benzinga Neuro
Wednesday, February 07, 2024
BeiGene Says Health Canada Approved BRUKINSA ...
Benzinga Newsdesk
Tuesday, February 06, 2024
JP Morgan's Bullish View On This Chinese Biotech, Says Pullback Creates Entry Point
Vandana Singh
Shares of US-listed Chinese stocks are tradin...
Benzinga Newsdesk
JP Morgan Assumes BeiGene at Overweight, Anno...
Benzinga Newsdesk
Wednesday, January 17, 2024
Shares of US-listed Chinese stocks are tradin...
Benzinga Newsdesk
Wednesday, January 10, 2024
As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?
Neil Dennis
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch